Yi Liu
Director/Board Member at GENOR BIOPHARMA HOLDINGS LIMITED
Network origin in Yi Liu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yi Liu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Graduate Degree | |
| Osaka University | College/University | Doctorate Degree | |
| Yale University | College/University | Graduate Degree | |
| University of Toronto | College/University | Doctorate Degree | |
| University of Durham | College/University | Masters Business Admin | |
| Baylor College of Medicine | College/University | Corporate Officer/Principal | |
| The Chinese University of Hong Kong | College/University | Undergraduate Degree | |
| City University of Hong Kong | College/University | Graduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
Tricor Services Ltd.
 Tricor Services Ltd. Miscellaneous Commercial ServicesCommercial Services Tricor Services Ltd. provides accounting and consulting services. The company is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director/Board Member | |
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Pharmaceuticals: Other | Director/Board Member | |
| LUYE PHARMA GROUP LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Ontario Cancer Institute | Corporate Officer/Principal | ||
| China Pharmaceutical University | College/University | Doctorate Degree | |
| Peking University Health Science Center | College/University | Undergraduate Degree | |
| Beijing Medical University | College/University | Undergraduate Degree | |
| Tongji Medical College of Huazhong University of Sci & Tech | College/University | Undergraduate Degree | |
Johnson & Johnson (China) Investment Ltd.
 Johnson & Johnson (China) Investment Ltd. Financial ConglomeratesFinance Part of Johnson & Johnson, Johnson & Johnson (China) Investment Ltd. is a Chinese company that provides investment services. The company is based in Shanghai, China. | Financial Conglomerates | Director/Board Member | |
| Xiangya School of Medicine | College/University | Corporate Officer/Principal | |
| ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Biotechnology | Chief Executive Officer Director/Board Member | |
| University of Colorado Boulder | College/University | Undergraduate Degree | |
| The Leeds School of Business | College/University | Masters Business Admin | |
| CHINA RUNDONG AUTO GROUP LIMITED | Specialty Stores | Corporate Secretary | |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Investment Managers | Private Equity Investor | |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Xiangya Hospital Central South University | College/University | Corporate Officer/Principal | |
WuXi AppTec (Shanghai) Co. Ltd.
 WuXi AppTec (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of WuXi AppTec Co., Ltd., WuXi AppTec (Shanghai) Co. Ltd. develops and manufactures pharmaceuticals. The company is based in Shanghai, China. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Chief Investment Officer Corporate Officer/Principal | ||
OncoImmune, Inc.
 OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pfizer Investment Co. Ltd.
 Pfizer Investment Co. Ltd. Financial ConglomeratesFinance Part of Pfizer Inc., Pfizer Investment Co. Ltd. is a Chinese company that provides investment and investments consulting services. The company is based in Shanghai, China. | Financial Conglomerates | Chief Tech/Sci/R&D Officer | |
| BONNY INTERNATIONAL HOLDING LIMITED | Apparel/Footwear | Corporate Secretary | |
| SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
| GEMPHARMATECH CO., LTD. | Biotechnology | Director/Board Member | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Yonjin Venture LLC
 Yonjin Venture LLC Investment ManagersFinance Yonjin Venture LLC (Yonjin Venture) is a venture capital subsidiary of Yongjin Group, Inc. founded in 2018. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| KEYMED BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Biotechnology | Director/Board Member | |
| CLOVER BIOPHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Pag Growth Zhuhai Holding Investment Management Co. Ltd. | Corporate Officer/Principal | ||
| Zhuhai Hillhouse Investment Management Holding Co. Ltd. | Corporate Officer/Principal | ||
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. | Corporate Officer/Principal | ||
| TECHSTAR ACQUISITION CORPORATION | Financial Conglomerates | Corporate Secretary | |
| Shanghai Medical College of Fudan University | College/University | Graduate Degree |
Statistics
International
| China | 24 |
| United States | 11 |
| Hong Kong | 7 |
| Cayman Islands | 6 |
| United Kingdom | 3 |
Sectoral
| Consumer Services | 21 |
| Health Technology | 15 |
| Finance | 7 |
| Commercial Services | 4 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 36 |
| Corporate Officer/Principal | 32 |
| Undergraduate Degree | 10 |
| Graduate Degree | 9 |
| Independent Dir/Board Member | 7 |
Most connected contacts
| Insiders | |
|---|---|
| Wen Chen | 14 |
| Dong Lyu | 13 |
| Yu Chen | 11 |
| Guan Hao Fung | 10 |
| Tie Ming Yu | 9 |
| Tak Wai Ip | 7 |
| Feng Guo | 6 |
| Tong Li | 6 |
| Mark F. Kubik | 6 |
| Shuhua Han | 5 |
| Lin Ni | 5 |
| Qi Bin Liang | 4 |
| Honghao Zhou | 4 |
| Huiyang Cheng | 1 |
| Qingtang Duan | 1 |
- Stock Market
- Insiders
- Yi Liu
- Company connections
